PRDM13 Antikörper (N-Term)
Kurzübersicht für PRDM13 Antikörper (N-Term) (ABIN927820)
Target
Alle PRDM13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Hund
-
Aufreinigung
- Purified
-
Immunogen
- PRDM13 antibody was raised in rabbit using the N terminal of PRDM13 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
PRDM13 Blocking Peptide, (ABIN939119), is also available for use as a blocking control in assays to test for specificity of this PRDM13 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- PRDM13 (PR Domain Containing 13 (PRDM13))
-
Andere Bezeichnung
- PRDM13
-
Hintergrund
- PRDM13 may be involved in transcriptional regulation. Synonyms: Polyclonal PRDM13 antibody, Anti-PRDM13 antibody, PR domain containing 13 antibody, MU-MB-20.220 antibody, PFM10 antibody.
Target
-